Video | Agriculture | Confidence | Economy | Energy | Employment | Finance | Media | Property | RBNZ | Science | SOEs | Tax | Technology | Telecoms | Tourism | Transport | Search

 


Rex Bionics hires top UK trade official as new CEO

Rex Bionics hires top UK trade official as new CEO

By Paul McBeth

Aug. 6 (BusinessDesk) - Rex Bionics, the local company which listed on the London Stock Exchange’s growth-orientated AIM market in May, has hired the UK government's trade guru Crispin Simon as its new boss, and brought forward a shift into bigger manufacturing facilities in Auckland.

The London-based company, which builds robotic exoskeletons that allows wheelchair users to walk, yesterday appointed Simon as its new chief executive when announcing its maiden first-half earnings since its reverse takeover of Union MedTech and listing on the AIM market. Simon has been managing director responsible for trade development for UK Trade & Investment since February 2012, and has previously worked in healthcare subsectors including medical technology.

Simon's appointment was one of several executive hires since Rex ramped up efforts for a global roll-out of its robotic exoskeletons, including the appointment of Tracey White to lead the Southern Hemisphere's North Shore-based operating company and Michael Heath as director of manufacturing, based in Auckland. White was previously the general manager of Siemens Healthcare New Zealand, while Heath's last role was at Bombadier in Belfast, Northern Ireland, manufacturing aircraft fuselages.

Rex raised 10 million pounds for a net 8.8 million pounds in its reverse takeover and listing, and had cash of 8.78 million pounds as at May 31, according to its first-half report. It had an operational cash outflow of 906,00 pounds, and share issuance costs of 391,000. The results capture one month of trading from Rex, and show the group made a loss of 1.25 million pounds on revenue of 176,000 pounds.

Of the funds raised in the May placement, Rex said 1.9 million pounds would be used to accelerate sales and marketing of the exoskeletons, 1.7 million pounds for scaling up manufacturing, 1.6 million pounds for research and development, 1.4 million pounds for general and administrative uses, and 2.2 million pounds for working capital.

Rex shifted its manufacturing and research and development into larger premises near Auckland in July, earlier than planned, it said in a statement.

"The move to the new facilities, whilst creating a temporary disruption to current manufacturing output, will enable the company to expand operations to meet its volume production requirements over the next three years without further disruption to manufacture," chairman David Macfarlane said in his report. "As part of the move, the company is implementing sophisticated new enterprise resource planning, production, quality systems and procedures to optimise manufacturing efficiency and ensure regulatory compliance."

The new facilities will let Rex scale up manufacturing, which extended to two exoskeletons a week, which it would then sell for about US$150,000 apiece.

As part of the shift, Rex is introducing new systems to improve its manufacturing efficiency and is embarking on a cost reduction programme to bring down the cost of building over time.

The company has to keep manufacturing based in New Zealand until 2017 as a condition of some $2.9 million it received in government grants to fund its research and development.

Before the transaction, New Zealand-based Rex reported sales of $976,000 in the six months ended Sept. 30 compared to $15,000 in the same period a year earlier, according to its admission document to list on the AIM exchange. It narrowed its net loss in the period to $722,000 from $2.1 million a year earlier. The New Zealand firm made a loss of $2.5 million on sales of $394,000 in the year ended March 31, 2013.

Since the 2011 financial year, Rex raised $4.1 million through share issues and $2.4 million in short-term borrowings.

Rex counts Jenny Morel-managed No 8 Ventures as its biggest shareholder with about 16 percent of the company, down from 38 percent before the AIM listing.

The AIM-listed shares last traded at 179.5 pence, just below the 180 pence placement price in May.

(BusinessDesk)

© Scoop Media

 
 
 
 
 
Business Headlines | Sci-Tech Headlines

 

BusinessDesk: APN's NZME Sees Future In Paywalls, Growth In Digital Sales

APN News & Media has touted a single newsroom concept for its NZME unit in New Zealand, similar to what Germany's Die Welt uses, saying an 'integrated sales proposition' is helping it win market share, including ... More>>

Labour Party: Global Milk Prices Now Lowest In 6 Years

The latest fall in the global dairy price has brought it to the lowest level in six years and shows there must be meaningful action in tomorrow’s Budget to diversify the economy, says Labour’s Finance spokesperson Grant Robertson. “Dairy prices ... More>>

BusinessDesk: NZ Inflation Expectations Creep Higher In June Survey

May 19 (BusinessDesk) - New Zealand businesses lifted their expectations for inflation over the next two years, sapping any immediate pressure on the Reserve Bank to cut interest rates, and prompting the kiwi dollar to jump higher. More>>

BusinessDesk: Lower Fuel Costs Drive Down NZ Producer Input, Output Prices

May 19 - Producer input and output prices fell in the first quarter, mainly reflecting lower fuel costs and weakness in prices of meat and dairy products. More>>

Media: Fairfax Media NZ Announces Senior Editorial Team

Fairfax Media New Zealand has today confirmed its new editorial leadership team, as part of a transformation of its newsrooms aimed at enhancing local and national journalism across digital and print. More>>

Science: Flavonoids Reduce Cold And Cough Risk

Flavonoids reduce cold and cough risk Research from the University of Auckland shows eating flavonoids – found in green tea, apples, blueberries, cocoa, red wine and onions – can significantly reduce the risk of catching colds and coughs. The research, ... More>>


BusinessDesk: RBNZ House Alert Speech The Catalyst For Government Action

Prime Minister John Key all but conceded that pressure from the Reserve Bank of New Zealand for concerted action on rampant Auckland house prices was one of the main catalysts for the government's weekend announcements about tightly ... More>>

BusinessDesk: How To Fall Foul Of The New Housing Tax Rules: Tips From IRD

Just because you rented out your investment property doesn't absolve you from paying tax, says the Inland Revenue Department in a summary of commonly made mistakes by non-professional property investors when it comes to their tax liability.More>>

Legal: Superdiversity Law, Policy And Business Stocktake Announced

Mai Chen, Managing Partner at Chen Palmer New Zealand Public and Employment Law Specialists and Adjunct Professor of Law at the University of Auckland, today announced the establishment ... More>>

Housing: More House Price Gains Expected

House price expectations remain high, with a net 56% of respondents expecting house prices will increase. Fears of higher interest rates are fading, consistent with the RBNZ’s signals this year. Affordability and a lack of houses for ... More>>

TDDA: State-Of-The-Art Drug Testing Laboratory To Open In Auckland

World leading drug testing agencies, The Drug Detection Agency (TDDA) and Omega Laboratories, open New Zealand laboratory More>>

Network: Bigpipe Launches Ultra-Fast Broadband Into Wellington

Bigpipe Launches Ultra-Fast Broadband into Wellington Naked broadband provider Bigpipe has extended its national reach, announcing today, the launch of its unlimited UFB offering into Wellington. The Spark Venture business is giving Wellingtonians the ... More>>

Get More From Scoop

 
 
 
 
 
 
 
 
 
Business
Search Scoop  
 
 
Powered by Vodafone
NZ independent news